Clinical Features and Associated Risk Factors of Protein-Losing Enteropathy
Overview
This study characterizes protein-losing enteropathy (PLE) in a cohort of 146 patients, comparing connective tissue disease-associated PLE (CTD-PLE) and lymphatic drainage disorder-associated PLE (LDD-PLE). Key findings include distinct clinical features and laboratory indicators that may assist in etiologic differentiation.
Background
Protein-losing enteropathy (PLE) represents a significant clinical challenge due to its diverse etiologies and associated complications such as malnutrition and increased infection risk. Understanding the clinical and laboratory features of PLE is crucial for accurate diagnosis and management. This study provides insights into the differences between CTD-PLE and LDD-PLE, which may enhance clinical decision-making.
Data Highlights
Characteristic
CTD-PLE (n=30)
LDD-PLE (n=116)
Median Age at Onset
Older
Younger
Edema
84.2%
84.2%
Serous Cavity Effusions
76.7%
76.7%
Thrombosis
More Frequent
Less Frequent
D-dimer Levels
Higher
Lower
Key Findings
CTD-PLE patients were older and predominantly female compared to LDD-PLE patients.
CTD-PLE was associated with higher levels of total cholesterol, triglycerides, and globulin.
LDD-PLE patients exhibited lower lymphocyte counts and more frequent diarrhea.
Age at onset, hemoglobin, and total cholesterol were identified as independent predictors of CTD-PLE.
19 out of 20 CTD-PLE patients on glucocorticoids plus immunosuppressants achieved symptom remission.
Clinical Implications
Clinicians should consider age, hemoglobin levels, and total cholesterol when evaluating patients for PLE, as these factors may aid in distinguishing between CTD-PLE and LDD-PLE. The findings underscore the importance of tailored treatment approaches based on the underlying etiology of PLE.
Conclusion
The study highlights the distinct clinical and laboratory patterns of PLE based on etiology, emphasizing the need for further validation of the proposed predictive model in larger cohorts.
